{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T18:05:40Z","timestamp":1765994740965,"version":"3.37.3"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T00:00:00Z","timestamp":1592870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T00:00:00Z","timestamp":1592870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81871124"],"award-info":[{"award-number":["81871124"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Orthop Surg Res"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Bone marrow lesions (BMLs) are a common finding in patients with osteoarthritis (OA), which are predictors of progression and pain related to cartilage damage in OA. The objective of the present research was to compare the short-term clinical effect of intramuscular calcitonin and oral celecoxib in treating knee BMLs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Patients and methods<\/jats:title>\n                <jats:p>Between January 2016 and December 2018, the medical records of patients with knee BMLs treated by intramuscular calcitonin or oral celecoxib were reviewed. Visual analog scale (VAS) and the Western Ontario and McMaster University Osteoarthritis Index (WOMAC) were used to assess knee pain and function, respectively. BMLs were assessed by MRI scans and were scored by the modified Whole-Organ MRI Score (WORMS). The safety of these two medications was also evaluated.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 123 eligible patients who received calcitonin treatment (<jats:italic>n<\/jats:italic> = 66) or celecoxib treatment (<jats:italic>n<\/jats:italic> = 57) were included. All patients were followed up clinically and radiographically for 3\u2009months. The VAS and WOMAC scores were lower statistically in calcitonin group than celecoxib group at 4-week and 3-month follow-up. For BMLs, the WORMS scores in the calcitonin group were significantly lower than the celecoxib group. Besides, statistically higher MRI improvement rates were found in the calcitonin group compared with the celecoxib group at 4-week follow-up (21.21% vs. 7.01%; <jats:italic>P<\/jats:italic> = 0.039) and 3-month follow-up (37.88% vs. 15.79%; <jats:italic>P<\/jats:italic> = 0.006).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Intramuscular calcitonin 50\u2009IU once daily demonstrated a better short-term effect for knee BML patients compared with oral celecoxib 200\u2009mg twice per day.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13018-020-01746-y","type":"journal-article","created":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T11:03:07Z","timestamp":1592910187000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Clinical effect of intramuscular calcitonin compared with oral celecoxib in the treatment of knee bone marrow lesions: a retrospective study"],"prefix":"10.1186","volume":"15","author":[{"given":"Jiaming","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wuyi","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengguo","family":"Gou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyang","family":"Huo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,23]]},"reference":[{"key":"1746_CR1","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/S0140-6736(16)31678-6","volume":"388","author":"GBD 2015 Disease and Injury Incidence and Prevalence Collaborators","year":"2016","unstructured":"GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1545\u2013602.","journal-title":"Lancet"},{"key":"1746_CR2","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1001\/jama.2018.0158","volume":"319","author":"AH Mokdad","year":"2018","unstructured":"Mokdad AH, Ballestros K, Echko M, et al. The state of US Health, 1990-2016: burden of diseases, injuries, and risk factors among US states. JAMA. 2018;319:1444\u201372.","journal-title":"JAMA."},{"key":"1746_CR3","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/S0140-6736(14)60802-3","volume":"386","author":"S Glyn-Jones","year":"2015","unstructured":"Glyn-Jones S, Palmer AJ, Agricola R, et al. Osteoarthritis. Lancet. 2015;386:376\u201387.","journal-title":"Lancet."},{"key":"1746_CR4","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1016\/S0140-6736(12)61689-4","volume":"380","author":"CJ Murray","year":"2012","unstructured":"Murray CJ, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2197\u2013223.","journal-title":"Lancet."},{"key":"1746_CR5","first-page":"646","volume":"81","author":"AD Woolf","year":"2003","unstructured":"Woolf AD, Pfleger B. Burden of major musculoskeletal conditions. Bull World Health Organ. 2003;81:646\u201356.","journal-title":"Bull World Health Organ"},{"key":"1746_CR6","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.arthro.2006.04.095","volume":"22","author":"CE Berger","year":"2006","unstructured":"Berger CE, Kroner AH, Kristen KH, et al. Transient bone marrow edema syndrome of the knee: clinical and magnetic resonance imaging results at 5\u2009years after core decompression. Arthroscopy. 2006;22:866\u201371.","journal-title":"Arthroscopy."},{"key":"1746_CR7","doi-asserted-by":"publisher","first-page":"541","DOI":"10.7326\/0003-4819-134-7-200104030-00007","volume":"134","author":"DT Felson","year":"2001","unstructured":"Felson DT, Chaisson CE, Hill CL, et al. The association of bone marrow lesions with pain in knee osteoarthritis. Ann Intern Med. 2001;134:541\u20139.","journal-title":"Ann Intern Med"},{"key":"1746_CR8","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s00590-012-1077-x","volume":"23","author":"CC Kesemenli","year":"2013","unstructured":"Kesemenli CC, Memisoglu K, Muezzinoglu US, Akansel G. Treatment for painful bone marrow edema by open wedge tibial osteotomy. Eur J Orthop Surg Traumatol. 2013;23:825\u20139.","journal-title":"Eur J Orthop Surg Traumatol"},{"key":"1746_CR9","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41584-018-0123-4","volume":"15","author":"IA Jones","year":"2019","unstructured":"Jones IA, Togashi R, Wilson ML, Heckmann N, Vangsness CT. Intra-articular treatment options for knee osteoarthritis. Nat Rev Rheumatol. 2019;15:77\u201390.","journal-title":"Nat Rev Rheumatol"},{"key":"1746_CR10","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.mcna.2019.10.007","volume":"104","author":"B Abramoff","year":"2020","unstructured":"Abramoff B, Caldera FE. Osteoarthritis: pathology, diagnosis, and treatment options. The Medical clinics of North America. 2020;104:293\u2013311.","journal-title":"The Medical clinics of North America"},{"key":"1746_CR11","doi-asserted-by":"publisher","first-page":"409","DOI":"10.2165\/00002512-199506050-00007","volume":"6","author":"FM Cicuttini","year":"1995","unstructured":"Cicuttini FM, Spector TD. Osteoarthritis in the aged. Epidemiological issues and optimal management. Drugs Aging. 1995;6:409\u201320.","journal-title":"Drugs Aging"},{"key":"1746_CR12","first-page":"391","volume":"27","author":"Guidelines for the diagnosis, investigation and management of osteoarthritis of the hip and knee","year":"1993","unstructured":"Guidelines for the diagnosis, investigation and management of osteoarthritis of the hip and knee. Report of a Joint Working Group of the British Society for Rheumatology and the Research Unit of the Royal College of Physicians. J R Coll Physicians Lond. 1993;27:391\u20136.","journal-title":"J R Coll Physicians Lond"},{"key":"1746_CR13","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1002\/art.1780381104","volume":"38","author":"MC Hochberg","year":"1995","unstructured":"Hochberg MC, Altman RD, Brandt KD, et al. Guidelines for the medical management of osteoarthritis. Part II. Osteoarthritis of the knee. American College of Rheumatology. Arthritis Rheum. 1995;38:1541\u20136.","journal-title":"Arthritis Rheum"},{"key":"1746_CR14","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S0002-9343(00)00490-3","volume":"109","author":"CH Chesnut 3rd","year":"2000","unstructured":"Chesnut CH 3rd, Silverman S, Andriano K, et al. A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group. Am J Med. 2000;109:267\u201376.","journal-title":"Am J Med"},{"key":"1746_CR15","doi-asserted-by":"publisher","first-page":"137","DOI":"10.2165\/00063030-200822030-00001","volume":"22","author":"MA Karsdal","year":"2008","unstructured":"Karsdal MA, Henriksen K, Arnold M, Christiansen C. Calcitonin: a drug of the past or for the future? Physiologic inhibition of bone resorption while sustaining osteoclast numbers improves bone quality. BioDrugs. 2008;22:137\u201344.","journal-title":"BioDrugs."},{"key":"1746_CR16","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.joca.2013.03.011","volume":"21","author":"MJ Kyrkos","year":"2013","unstructured":"Kyrkos MJ, Papavasiliou KA, Kenanidis E, Tsiridis E, Sayegh FE, Kapetanos GA. Calcitonin delays the progress of early-stage mechanically induced osteoarthritis. In vivo, prospective study. Osteoarthr Cartil. 2013;21:973\u201380.","journal-title":"Osteoarthr Cartil"},{"key":"1746_CR17","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.joca.2011.01.008","volume":"19","author":"RH Nielsen","year":"2011","unstructured":"Nielsen RH, Bay-Jensen AC, Byrjalsen I, Karsdal MA. Oral salmon calcitonin reduces cartilage and bone pathology in an osteoarthritis rat model with increased subchondral bone turnover. Osteoarthr Cartil. 2011;19:466\u201373.","journal-title":"Osteoarthr Cartil"},{"key":"1746_CR18","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.joca.2004.08.005","volume":"12","author":"H El Hajjaji","year":"2004","unstructured":"El Hajjaji H, Williams JM, Devogelaer JP, Lenz ME, Thonar EJ, Manicourt DH. Treatment with calcitonin prevents the net loss of collagen, hyaluronan and proteoglycan aggregates from cartilage in the early stages of canine experimental osteoarthritis. Osteoarthr Cartil. 2004;12:904\u201311.","journal-title":"Osteoarthr Cartil"},{"key":"1746_CR19","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.bone.2005.04.032","volume":"37","author":"YZ Bagger","year":"2005","unstructured":"Bagger YZ, Tanko LB, Alexandersen P, et al. Oral salmon calcitonin induced suppression of urinary collagen type II degradation in postmenopausal women: a new potential treatment of osteoarthritis. Bone. 2005;37:425\u201330.","journal-title":"Bone."},{"key":"1746_CR20","doi-asserted-by":"publisher","first-page":"3205","DOI":"10.1002\/art.22075","volume":"54","author":"DH Manicourt","year":"2006","unstructured":"Manicourt DH, Azria M, Mindeholm L, Thonar EJ, Devogelaer JP. Oral salmon calcitonin reduces Lequesne\u2019s algofunctional index scores and decreases urinary and serum levels of biomarkers of joint metabolism in knee osteoarthritis. Arthritis Rheum. 2006;54:3205\u201311.","journal-title":"Arthritis Rheum"},{"key":"1746_CR21","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.joca.2009.08.004","volume":"18","author":"MA Karsdal","year":"2010","unstructured":"Karsdal MA, Byrjalsen I, Henriksen K, et al. The effect of oral salmon calcitonin delivered with 5-CNAC on bone and cartilage degradation in osteoarthritic patients: a 14-day randomized study. Osteoarthr Cartil. 2010;18:150\u20139.","journal-title":"Osteoarthr Cartil"},{"key":"1746_CR22","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1136\/annrheumdis-2017-211396","volume":"76","author":"A Kuttapitiya","year":"2017","unstructured":"Kuttapitiya A, Assi L, Laing K, et al. Microarray analysis of bone marrow lesions in osteoarthritis demonstrates upregulation of genes implicated in osteochondral turnover, neurogenesis and inflammation. Ann Rheum Dis. 2017;76:1764\u201373.","journal-title":"Ann Rheum Dis"},{"key":"1746_CR23","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1046\/j.1365-2036.2003.01454.x","volume":"17","author":"R Micklewright","year":"2003","unstructured":"Micklewright R, Lane S, Linley W, McQuade C, Thompson F, Maskrey N. Review article: NSAIDs, gastroprotection and cyclo-oxygenase-II-selective inhibitors. Aliment Pharmacol Ther. 2003;17:321\u201332.","journal-title":"Aliment Pharmacol Ther"},{"key":"1746_CR24","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.4065\/74.11.1095","volume":"74","author":"WG Bensen","year":"1999","unstructured":"Bensen WG, Fiechtner JJ, McMillen JI, et al. Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trial. Mayo Clin Proc. 1999;74:1095\u2013105.","journal-title":"Mayo Clin Proc"},{"key":"1746_CR25","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1016\/S0140-6736(19)30417-9","volume":"393","author":"DJ Hunter","year":"2019","unstructured":"Hunter DJ, Bierma-Zeinstra S. Osteoarthritis. Lancet (London, England). 2019;393:1745\u201359.","journal-title":"Lancet (London, England)"},{"key":"1746_CR26","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1002\/art.1780290816","volume":"29","author":"R Altman","year":"1986","unstructured":"Altman R, Asch E, Bloch D, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum. 1986;29:1039\u201349.","journal-title":"Arthritis Rheum"},{"key":"1746_CR27","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1136\/ard.16.4.494","volume":"16","author":"JH Kellgren","year":"1957","unstructured":"Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis. 1957;16:494\u2013502.","journal-title":"Ann Rheum Dis"},{"key":"1746_CR28","doi-asserted-by":"publisher","first-page":"330","DOI":"10.7326\/0003-4819-139-5_Part_1-200309020-00008","volume":"139","author":"DT Felson","year":"2003","unstructured":"Felson DT, McLaughlin S, Goggins J, et al. Bone marrow edema and its relation to progression of knee osteoarthritis. Ann Intern Med. 2003;139:330\u20136.","journal-title":"Ann Intern Med"},{"key":"1746_CR29","doi-asserted-by":"publisher","first-page":"e263","DOI":"10.3928\/01477447-20150402-53","volume":"38","author":"F Gao","year":"2015","unstructured":"Gao F, Sun W, Li Z, Guo W, Kush N, Ozaki K. Intractable bone marrow edema syndrome of the hip. Orthopedics. 2015;38:e263\u201370.","journal-title":"Orthopedics."},{"key":"1746_CR30","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1471-2474-9-45","volume":"9","author":"N Aigner","year":"2008","unstructured":"Aigner N, Meizer R, Petje G, Meizer E, Abdelkafy A, Landsiedl F. Natural course of intra-articular shifting bone marrow edema syndrome of the knee. BMC Musculoskelet Disord. 2008;9:45.","journal-title":"BMC Musculoskelet Disord"},{"key":"1746_CR31","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.joca.2003.11.003","volume":"12","author":"CG Peterfy","year":"2004","unstructured":"Peterfy CG, Guermazi A, Zaim S, et al. Whole-Organ Magnetic Resonance Imaging Score (WORMS) of the knee in osteoarthritis. Osteoarthr Cartil. 2004;12:177\u201390.","journal-title":"Osteoarthr Cartil"},{"key":"1746_CR32","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1093\/rheumatology\/16.4.257","volume":"16","author":"PJ Scott","year":"1977","unstructured":"Scott PJ, Huskisson EC. Measurement of functional capacity with visual analogue scales. Rheumatol Rehabil. 1977;16:257\u20139.","journal-title":"Rheumatol Rehabil"},{"key":"1746_CR33","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/ard.52.8.557","volume":"52","author":"P Dieppe","year":"1993","unstructured":"Dieppe P, Cushnaghan J, Young P, Kirwan J. Prediction of the progression of joint space narrowing in osteoarthritis of the knee by bone scintigraphy. Ann Rheum Dis. 1993;52:557\u201363.","journal-title":"Ann Rheum Dis"},{"key":"1746_CR34","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.1002\/art.22851","volume":"56","author":"DT Felson","year":"2007","unstructured":"Felson DT, Niu J, Guermazi A, et al. Correlation of the development of knee pain with enlarging bone marrow lesions on magnetic resonance imaging. Arthritis Rheum. 2007;56:2986\u201392.","journal-title":"Arthritis Rheum"},{"key":"1746_CR35","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1136\/annrheumdis-2011-200970","volume":"71","author":"LL Laslett","year":"2012","unstructured":"Laslett LL, Dor\u00e9 DA, Quinn SJ, et al. Zoledronic acid reduces knee pain and bone marrow lesions over 1\u2009year: a randomised controlled trial. Ann Rheum Dis. 2012;71:1322\u20138.","journal-title":"Ann Rheum Dis"},{"key":"1746_CR36","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1136\/ard.2008.096834","volume":"68","author":"FW Roemer","year":"2009","unstructured":"Roemer FW, Guermazi A, Javaid MK, et al. Change in MRI-detected subchondral bone marrow lesions is associated with cartilage loss: the MOST Study. A longitudinal multicentre study of knee osteoarthritis. Ann Rheum Dis. 2009;68:1461\u20135.","journal-title":"Ann Rheum Dis"},{"key":"1746_CR37","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1148\/radiology.215.3.r00jn05835","volume":"215","author":"M Zanetti","year":"2000","unstructured":"Zanetti M, Bruder E, Romero J, Hodler J. Bone marrow edema pattern in osteoarthritic knees: correlation between MR imaging and histologic findings. Radiology. 2000;215:835\u201340.","journal-title":"Radiology."},{"key":"1746_CR38","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.neuropharm.2010.07.022","volume":"59","author":"RM Rezende","year":"2010","unstructured":"Rezende RM, Paiva-Lima P, Dos Reis WGP, Cam\u00ealo VM, Bakhle YS, de Francischi JN. Celecoxib induces tolerance in a model of peripheral inflammatory pain in rats. Neuropharmacology. 2010;59:551\u20137.","journal-title":"Neuropharmacology."},{"key":"1746_CR39","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1136\/ard.2010.140848","volume":"70","author":"LM Wildi","year":"2011","unstructured":"Wildi LM, Raynauld J-P, Martel-Pelletier J, et al. Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6\u2009months after initiation of therapy: a randomised, double-blind, placebo-controlled pilot study using MRI. Ann Rheum Dis. 2011;70:982\u20139.","journal-title":"Ann Rheum Dis"},{"key":"1746_CR40","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.semarthrit.2009.10.003","volume":"40","author":"J-P Raynauld","year":"2010","unstructured":"Raynauld J-P, Martel-Pelletier J, Beaulieu A, et al. An open-label pilot study evaluating by magnetic resonance imaging the potential for a disease-modifying effect of celecoxib compared to a modelized historical control cohort in the treatment of knee osteoarthritis. Semin Arthritis Rheum. 2010;40:185\u201392.","journal-title":"Semin Arthritis Rheum"},{"key":"1746_CR41","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2165\/00024677-200403020-00006","volume":"3","author":"M Munoz-Torres","year":"2004","unstructured":"Munoz-Torres M, Alonso G, Raya MP. Calcitonin therapy in osteoporosis. Treat Endocrinol. 2004;3:117\u201332.","journal-title":"Treat Endocrinol"},{"key":"1746_CR42","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.joca.2006.10.012","volume":"15","author":"NA Papaioannou","year":"2007","unstructured":"Papaioannou NA, Triantafillopoulos IK, Khaldi L, Krallis N, Galanos A, Lyritis GP. Effect of calcitonin in early and late stages of experimentally induced osteoarthritis. A histomorphometric study. Osteoarthr Cartil. 2007;15:386\u201395.","journal-title":"Osteoarthr Cartil"},{"key":"1746_CR43","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1359\/JBMR.040609","volume":"19","author":"C Behets","year":"2004","unstructured":"Behets C, Williams JM, Chappard D, Devogelaer JP, Manicourt DH. Effects of calcitonin on subchondral trabecular bone changes and on osteoarthritic cartilage lesions after acute anterior cruciate ligament deficiency. J Bone Miner Res. 2004;19:1821\u20136.","journal-title":"J Bone Miner Res"},{"key":"1746_CR44","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1136\/ard.2007.071977","volume":"67","author":"EA Haavardsholm","year":"2008","unstructured":"Haavardsholm EA, Boyesen P, Ostergaard M, Schildvold A, Kvien TK. Magnetic resonance imaging findings in 84 patients with early rheumatoid arthritis: bone marrow oedema predicts erosive progression. Ann Rheum Dis. 2008;67:794\u2013800.","journal-title":"Ann Rheum Dis"},{"key":"1746_CR45","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1053\/sarh.2002.50014","volume":"32","author":"TK Arayssi","year":"2003","unstructured":"Arayssi TK, Tawbi HA, Usta IM, Hourani MH. Calcitonin in the treatment of transient osteoporosis of the hip. Semin Arthritis Rheum. 2003;32:388\u201397.","journal-title":"Semin Arthritis Rheum"},{"key":"1746_CR46","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/BF02230335","volume":"15","author":"M Varenna","year":"1996","unstructured":"Varenna M, Sinigaglia L, Binelli L, Beltrametti P, Gallazzi M. Transient osteoporosis of the hip: a densitometric study. Clin Rheumatol. 1996;15:169\u201373.","journal-title":"Clin Rheumatol"},{"key":"1746_CR47","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.2147\/JPR.S158718","volume":"11","author":"J Zhou","year":"2018","unstructured":"Zhou J, Li T, Li L, Xue Y. Clinical efficacy of calcitonin compared to diclofenac sodium in chronic nonspecific low back pain with type I Modic changes: a retrospective study. J Pain Res. 2018;11:1335\u201342.","journal-title":"J Pain Res"},{"key":"1746_CR48","doi-asserted-by":"publisher","first-page":"284873","DOI":"10.1155\/2013\/284873","volume":"2013","author":"M Maldonado","year":"2013","unstructured":"Maldonado M, Nam J. The role of changes in extracellular matrix of cartilage in the presence of inflammation on the pathology of osteoarthritis. Biomed Res Int. 2013;2013:284873.","journal-title":"Biomed Res Int"},{"key":"1746_CR49","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s13238-010-0002-5","volume":"1","author":"EA Lin","year":"2010","unstructured":"Lin EA, Liu CJ. The role of ADAMTSs in arthritis. Protein Cell. 2010;1:33\u201347.","journal-title":"Protein Cell"},{"issue":"2","key":"1746_CR50","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ejpain.2006.02.013","volume":"11","author":"JM Bjordal","year":"2007","unstructured":"Bjordal JM, Klovning A, Ljunggren AE, Sl\u00f8rdal L. Short-term efficacy of pharmacotherapeutic interventions in osteoarthritic knee pain: a meta-analysis of randomised placebo-controlled trials. European journal of pain (London, England). 2007;11(2):125\u201338.","journal-title":"European journal of pain (London, England)"},{"issue":"12","key":"1746_CR51","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1016\/j.joca.2015.07.001","volume":"23","author":"JY Reginster","year":"2015","unstructured":"Reginster JY, Reiter-Niesert S, Bruy\u00e8re O, et al. Recommendations for an update of the 2010 European regulatory guideline on clinical investigation of medicinal products used in the treatment of osteoarthritis and reflections about related clinically relevant outcomes: expert consensus statement. Osteoarthr Cartil. 2015;23(12):2086\u201393.","journal-title":"Osteoarthr Cartil"},{"key":"1746_CR52","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1002\/jor.23844","volume":"36","author":"T Alliston","year":"2018","unstructured":"Alliston T, Hernandez CJ, Findlay DM, Felson DT, Kennedy OD. Bone marrow lesions in osteoarthritis: what lies beneath. Journal of orthopaedic research : official publication of the Orthopaedic Research Society. 2018;36:1818\u201325.","journal-title":"Journal of orthopaedic research : official publication of the Orthopaedic Research Society"},{"key":"1746_CR53","first-page":"35","volume":"18","author":"EF McCarthy","year":"1998","unstructured":"McCarthy EF. The pathology of transient regional osteoporosis. Iowa Orthop J. 1998;18:35\u201342.","journal-title":"Iowa Orthop J"},{"key":"1746_CR54","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/S8756-3282(03)00164-9","volume":"33","author":"CE Berger","year":"2003","unstructured":"Berger CE, Kroner AH, Minai-Pour MB, Ogris E, Engel A. Biochemical markers of bone metabolism in bone marrow edema syndrome of the hip. Bone. 2003;33:346\u201351.","journal-title":"Bone."},{"key":"1746_CR55","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s00296-011-2141-2","volume":"32","author":"EF Eriksen","year":"2012","unstructured":"Eriksen EF, Ringe JD. Bone marrow lesions: a universal bone response to injury? Rheumatol Int. 2012;32:575\u201384.","journal-title":"Rheumatol Int"}],"container-title":["Journal of Orthopaedic Surgery and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-020-01746-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13018-020-01746-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-020-01746-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T09:17:22Z","timestamp":1650532642000},"score":1,"resource":{"primary":{"URL":"https:\/\/josr-online.biomedcentral.com\/articles\/10.1186\/s13018-020-01746-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,23]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1746"],"URL":"https:\/\/doi.org\/10.1186\/s13018-020-01746-y","relation":{},"ISSN":["1749-799X"],"issn-type":[{"type":"electronic","value":"1749-799X"}],"subject":[],"published":{"date-parts":[[2020,6,23]]},"assertion":[{"value":"6 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Medical Ethics Committee of Tianjin Medical University General Hospital (China) with ethical no. IRB2019-WZ-070 and was conducted in accordance with the ethical standards of the Declaration of Helsinki and its later amendments. All patients received information about the study and agreed to participate by signing the informed consent form. Informed consent was obtained from all individual participants included in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"230"}}